Puma Biotechnology (PBYI) Other Working Capital Changes (2018 - 2026)
Puma Biotechnology's (PBYI) quarterly Other Working Capital Changes came in at -$60000.0 in Q1 2026, down 957.14% YoY from $7000.0 in Q1 2025, and down 330.77% on a QoQ basis from $26000.0 in Q4 2025.
Puma Biotechnology (PBYI) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Puma Biotechnology (PBYI) has 9 years of Other Working Capital Changes data on file, last reported at -$60000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 957.14% year-over-year to -$60000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98000.0 (up 162.42% YoY) and the FY2025 annual result came in at $165000.0, up 120.1% from the prior year.
- Other Working Capital Changes fell to -$60000.0 in Q1 2026, from $26000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.7 million in Q2 2022 to a low of -$2.0 million in Q1 2023.
- A 5-year average of -$14764.7 and a median of -$14000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 3385.71% in 2022, down 41925.0% in 2022.
- Tracing PBYI's Other Working Capital Changes over 5 years: stood at -$1.7 million in 2022, then soared by 35.99% to -$1.1 million in 2023, then jumped by 86.52% to -$145000.0 in 2024, then surged by 117.93% to $26000.0 in 2025, then tumbled by 330.77% to -$60000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$60000.0 (Q1 2026), $26000.0 (Q4 2025), and $157000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Puma Biotechnology | 451.24 Mn | 357.33 Mn | 44.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Jun 30, 2026 | 3,000.00 |
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 157,000.00 |
| Sep 30, 2025 | 157,000.00 |
| Sep 30, 2025 | 157,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Dec 31, 2024 | -145,000.00 |